Our murine LR model further demonstrated that inhibition of HMGB1 improved liver function, reduced steatosis, enhanced regeneration, and decreased hepatic cell death, highlighting the therapeutic potential of targeting HMGB1 in mitigating liver injury and promoting regeneration post LR. Here, HMGB1 is linked to steatosis.